E.R. Morgan

Statistics

Publications

Citations

133

H-Index

Active since

1956

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

E.R. Morgan is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in pharmacology, medicinal chemistry, and natural sciences.

Top concepts

PharmacologyMedicineBiochemistryNatural SciencesMedicinal ChemistryDrug DiscoveryEducationMetabolismPhysiologyDermatology

Publications per year

1956–1996

Publications

Anti-androgenic activity of spironolactone

S. L. Steelman, J. R. Brooks, E.R. Morgan et al. · Steroids · 1969 · 60 citations

Medicinal Chemistry, Biochemistry, Natural Sciences +4

Substituted pyrazolo corticoids as topical antiinflammatory agents

John Hannah, Kenneth Kelly, Arthur A. Patchett et al. · Journal of Medicinal Chemistry · 1975 · 23 citations

Substituted Pyrazolo Corticoids, Medicinal Chemistry, Anti-inflammatory +14

Absorption and Excretion of 17, 21-Dihydroxy-20-Ketosteroids in Dogs

Robert Silber, E.R. Morgan · Clinical Chemistry · 1956 · 21 citations · Full text

Animal Physiology, Plasma Half-life, Position 9 +14

Heterocyclic corticosteroids: I. Biological properties of the 6, 16α-dimethyl-4, 6-pregnadiene-11β, 17, 21-triol-20-one/ phenylpyrazole-21-acetate and its 21-desoxy derivative

S. L. Steelman, E.R. Morgan, M. S. Glitzer · Steroids · 1971 · 19 citations

Molecular Pharmacology, Medicinal Chemistry, Heterocyclic +13

Inhibition of testosterone 5 alpha-reductase: evidence for tissue-specific regulation of thromboxane A2 receptors.

Katsuhiro Higashiura, B Blaney, E.R. Morgan et al. · Journal of Pharmacology and Experimental Therapeutics · 1996 · 10 citations

1–5 of 5